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Genetic basis of salt-susceptibility in the Sabra rat model of hyperten-
sion. The Sabra salt-sensitive SBH/y and salt-resistant SBN/y rats consti-
tute a unique experimental model of hypertension in which salt-suscepti-
bility is genetically determined and expressed only after salt-loading,
without the development of spontaneous hypertension. To determine the
genetic basis of salt-susceptibility in the Sabra rats, the candidate gene and
total genome screen approaches were adopted. The likely candidate genes
in this model incorporate salt-related physiological mechanisms such as
the nitric oxide system, the arginine vasopressin axis and the epithelial
sodium channel. In the random genome search scheme for culprit genes,
SBH/y and SBN/y were cross-bred. A highly unusual and composite mode
of transmission of salt-susceptibility was found in this cross, emphasizing
the complexity of the genetic basis of salt-susceptibility. Linkage analysis
of the entire rat genome with a large number of widely distributed
microsatellite markers identified three putative gene loci on chromosomes
1 and 17 that contribute importantly to salt-sensitivity and/or resistance,
and uncovered sex specificity in the role that salt-susceptibility genes fulfill
in the development of hypertension.
In the complex, polygenic and multifactorial form of disease
that comprises hypertension, high dietary salt intake remains one
of the more important environmental factors that predispose
individuals to the development of hypertension. Experimental and
clinical data suggest that the individual’s blood pressure (BP)
response to salt loading, categorized as salt-sensitivity when BP
rises and salt-resistance when BP is unaffected, is determined by
salt-susceptibility genes [1]. The search for these susceptibility
genes in humans has been hampered thus far by the inability to
isolate this phenotype from the numerous other confounding
elements that determine BP, such as the effects of dietary factors
other than salt, age, body mass, gender, the multitude of environ-
mental factors, and the involvement of additional genes that
induce the development of “spontaneous” hypertension (Fig. 1).
The closest one has been able so far to close in upon the specific
genes for salt-susceptibility may have been by studying the Dahl
experimental model of hypertension, one of the two major models
of salt-induced hypertension. The Dahl rats were originally devel-
oped as a model of salt-sensitivity by L.K. Dahl and further inbred
and developed by J. Rapp a decade ago [2, 3]. Breeding experi-
ments and cosegregation studies using molecular genetic tools in
crosses between the Dahl-derived rats and other rat strains have
revealed a relatively large number of BP-relevant quantitative
trait loci (QTL), presumably incorporating the salt-susceptibility
genes, on chromosomes 1, 2, 3, 5, 7, 9, 10, 13 and 17 [4–9]. Which
of these quantitative trait loci relate to salt-susceptibility per se,
however, is unclear because the Dahl rats, in addition to express-
ing salt-sensitivity and resistance, develop spontaneous hyperten-
sion as a function of age, even in the absence of dietary salt
exposure [10]. It may thus not possible to differentiate between
QTLs that encode genes for salt-susceptibility from those that
encode for spontaneous hypertension in the Dahl model of salt
sensitivity. For this reason, the Dahl experimental model of
hypertension, although being a classical model of spontaneous
hypertension on which salt-susceptibility is genetically superim-
posed, which is in fact reminiscent of the clinical phenotype of
hypertension in humans, may be less of an ideal experimental
model for the study of the genetic basis of salt-susceptibility. A
preferable experimental model would be one that expresses
salt-susceptibility as an isolated BP phenotype, not confounded by
spontaneous hypertension. Such is the Sabra model of salt-
susceptibility, the second major model of salt-induced hyperten-
sion.
The Sabra model of hypertension was developed over two
decades ago by D. Ben-Ishay and co-workers as a new rat model
of salt-sensitive and salt-resistant hypertension that is genetically
and phenotypically distinct from the Dahl strains [11, 12]. Re-
cently, we undertook secondary inbreeding of the original colony,
rendering the SBH/y and SBN/y animals phenotypically homoge-
neous and genetically highly suitable for studying the genetic basis
for salt-susceptibility [13]. Phenotypically, the Sabra rat model of
hypertension expresses hypertension only after salt-loading, with-
out ever developing spontaneous hypertension [13]. This feature
bestows upon the Sabra model an advantage insofar as the ability
to study the genetic basis of salt-susceptibility without the con-
founding element of essential hypertension. Screening of the
Sabra genome with microsatellite markers revealed a relatively
high degree of polymorphism between the salt-sensitive SBH/y
and salt-resistant SBN/y strains [13]. This important feature in the
Sabra model allows cross-breeding between the two strains,
without necessarily requiring crosses with foreign strains.
We presently report on the ongoing efforts to determine the
genetic basis of salt-susceptibility in the Sabra experimental model
of hypertension. The two standard strategies for detection of
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disease genes are presented, the candidate gene approach and the
steps taken so far in positional cloning.
CANDIDATE GENES FOR SALT-SUSCEPTIBILITY IN THE
SABRA MODEL OF HYPERTENSION
Based on the known pathophysiological mechanisms of salt-
susceptibility in the rat and published studies in the Sabra rat
model of hypertension, a large number of candidate genes be-
come relevant. The relevance of the nitric oxide system, the
arginine vasopressin axis and the epithelial sodium channel are
discussed below.
Nitric oxide system
Nitric oxide (NO) is a signaling molecule that is generated by
the enzyme NO synthase (NOS). Three major isoforms have been
identified: isoform I (nNOS) present in neuronal and epithelial
cells, isoform II (iNOS) present in macrophages and vascular
smooth muscle, and isoform III (eNOS) present in endothelial
cells [14]. Expression of nNOS and eNOS is constitutive, whereas
expression of iNOS is inducible. Among its diverse actions,
vasodilation in particular renders NO a physiologically significant
regulator of systemic and regional hemodynamics [14]. It is
currently thought that resistance vessels are physiologically in a
state of active dilator tone mediated by endogenous NO, and that
NO acts as an important physiological regulator of normal BP
[14]. Even though its role in the pathogenesis of essential hyper-
tension remains controversial, there is a evidence to suggest a
contributory role of NO in salt-induced hypertension. Chen and
Sanders [15] have shown in the salt-sensitive Dahl rat fed 8%
NaCl that by administration of L-arginine, which increases NO
production, they prevented the development of hypertension.
Administration of dexamethasone, which prevents expression of
inducible NOS but not of constitutive NOS, along with L-arginine
prevented the protective effect of L-arginine, suggesting that
protection required activity of iNOS. Rees, Ben-Ishay and
Moncada [16] studied the role of NO in the Sabra model of
salt-susceptibility by inhibiting NO-synthase with L-NMMA and
simultaneously administering a vasoconstrictor. They found a
greater pressor effect in the salt-resistant than in the salt-sensitive
strain, suggesting decreased NO generation in the latter leading to
hypertension, and increased NO generation in former accounting
for the resistance to the rise in BP. This conclusion was supported
by a subsequent study by Lippoldt et al [17], who found that
expression of inducible and neural NO synthase genes was lower
in SBH/y than in SBN/y before and after salt-loading. Of note is
that gene expression of endothelial NO synthase (eNOS) was not
different among the Sabra strains. This latter observation is of
interest with regards to the role of NOS in salt-induced hyperten-
sion, as until now, the constitutive isoform III in endothelial cells
has been considered to be the major regulator of arterial tone, at
least under physiological conditions. On the other hand, salt-
induced hypertension is a pathophysiological condition, and the
inducible isoform II has been shown to play a role in vascular
reactivity in a variety of pathophysiological conditions [14]. The
NOS isoform I may influence vascular tone because of its pres-
ence in perivascular nerves and its central actions causing a
decrease in sympathetic nerve traffic and BP [14].
Based on the above data, the NO system deserves to be
considered a major candidate gene in salt-susceptible hyperten-
sion. Detection of the NO related culprit genes in salt-suscepti-
bility, however, remains a very complex and tedious task. As
pointed out by Dominiczak and Bohr [14], NO metabolism and
actions involve at least eight significant intermediary steps, each of
which may be in itself pivotal to the pathogenesis of salt-sensitive
hypertension. Thus, although the NO system is unquestionably a
worthy candidate gene, further extensive studies are needed at the
molecular genetic level in the salt-sensitive models of hyperten-
sion before the NO-related genes can be directly implicated in
salt-susceptibility.
The arginine vasopressin axis
Arginine vasopressin (AVP) has been studied extensively over
the years with respect to hypertension. Although direct evidence
for a central role of AVP in experimental hypertension is not
abundant, the peptide has been proposed as a significant contrib-
utor to the pathogenesis of salt-related hypertension [18–20]. If
AVP is indeed involved in salt-induced hypertension, the sug-
gested major pathogenetic mechanisms are most likely an en-
hanced pressor effect of AVP and increased sodium retention in
the salt-sensitive strain. AVP has been shown to modulate sodium
reabsorption in the renal collecting duct [21]. One suggested
mechanism for the latter effect of AVP is regulation of the
epithelial sodium channel activity [22, 23]. Other possible mech-
anisms are a direct central nervous system effect of AVP on BP
regulation [24] and an interaction of AVP with the sympathetic
nervous system in the regulation of BP [19].
Experimental evidence for involvement of AVP in the patho-
genesis of salt-induced hypertension in the Dahl rats is sound but
not conclusive. In the Dahl model of hypertension, plasma AVP
are similar at baseline in the S and R strains [25]. When the
animals are exposed to high salt diet which leads to hypertension,
plasma AVP levels rise more significantly in S than in R [25]. In
one study, it was found that blockade of the pressor effect of AVP
did not lead to a reduction in BP in the hypertensive S strain [25].
In contrast, in another study, an AVP V1A receptor antagonist
given after 10 days of high salt-intake attenuated the rise in BP
[26]. Finally, rats with diabetes insipidus failed to develop hyper-
tension when loaded with DOCA-salt [20]. In the Sabra model of
hypertension, a substantial body of evidence suggests involvement
of the AVP system in salt susceptibility. Studies performed during
the past decade have persistently shown disparate expression of
the AVP gene among the salt-sensitive SBH/y and salt-resistant
SBN/y strains. Enhanced expression of the AVP gene was found
in the SBH/y strain at the level of the hypothalamus with greater
Fig. 1. Variables that affect blood pressure (BP).
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AVPmRNA content [27, 28], of the pituitary with greater AVP
content [27], and of the peripheral circulation with increased AVP
levels [28], compared to the salt resistant SBN/y strain. At the
level of the kidney, increased activation of the AVP system was
also found in the salt-sensitive strain, that is, in SBH/y, spontane-
ous urine excretion in prior to salt-loading was lower and urine
osmolality higher then in the salt-resistant SBN/y rat [29].
Based on the above, the AVP complex appears to be estab-
lished as a likely candidate gene for hypertension in the Sabra
model of salt-susceptibility. As with the NO system, the continu-
ing task involved in identifying the culprit genes within the AVP
system is complex and very tedious, as numerous steps are
involved in the metabolism and actions of AVP, all of which may
affect BP regulation. So far, the AVP gene complex has not been
differentially sequenced in the Sabra strains and no cosegregation
studies of AVP genes with salt-induced hypertension have been
published in the Sabra rats or the Dahl model of salt-susceptibil-
ity.
Epithelial sodium channel
The epithelial sodium channel (ENaC), which is found at the
apical membrane of salt-reabsorbing epithelia in the kidney [30],
is an important mechanism in the maintenance of salt-homeosta-
sis. The protein is composed of three subunits: a, b and g [30]. Its
activity in the distal nephron is regulated by aldosterone and
vasopressin [23]. Mutations of the b and g subunits have been
linked to spontaneous unregulated hyperactivity of the channel,
leading to excessive renal sodium reabsorption and the develop-
ment of hypertension in the clinical entity known as the Liddle’s
syndrome [31]. Mutations of the a subunit have also resulted in
increased channel activity. Since genes that control sodium ho-
meostasis are likely to fulfill a major role in salt-sensitive hyper-
tension, the ENaC becomes a natural candidate gene for salt-
induced hypertension.
In the Dahl model of hypertension, only a limited amount of
work has been published to date on the potential role of the
ENaC in the pathogenesis of salt-sensitivity. Of note are findings
in a cross between Dahl S and Lewis rats in which linkage analysis
detected one quantitative trait locus on chromosome 1 that could
incorporate the genes for the b or g subunits of ENaC [4]. In the
Sabra model of hypertension, an effort was undertaken to detect
mutations in genes encoding the subunits composing the ENaC.
Grunder et al [22] sequenced the part of the genes encoding the
cytoplasmatic carboxyl terminus (C-terminus) of each of the three
subunits, as the mutations leading to Liddle’s syndrome have been
found almost exclusively in that portion of the genes [31]. No
differences were found in the sequences of the a or b subunits in
SBH/y and SBN/y rats from the published sequences [22]. For the
g subunit, two identical polymorphisms were found in both SBH/y
and SBN/y: the codon for the amino acid 573 was TGG instead of
the published codon TGT, changing a Cys into a Trp and the
codon for Cys 542 was changed from TGT to TGC without
changing the amino acid [22]. Thus, SBH/y and SBN/y expressed
mutations at the 573 and 542 sites, but there were no strain
differences. Expression of the g-C573W polymorphism in Xeno-
pus oocytes did not alter ENaC activity [22]. This latter finding
and the lack of difference between the salt-sensitive and salt-
resistant strains render this particular mutation not likely to be
related to the pathogenesis of salt-susceptibility in the Sabra
model of hypertension. It is possible, however, that in other parts
of the ENaC mutations may be involved in the generation of
hypertension. Mutations also outside the coding region, for
example, in the promoter of one of the genes, could lead to
misregulation of a subunit and altered activity of the sodium
channel. A further possibility is that a mutant gene coding for a
protein that is interacting with the ENaC to regulate its activity
accounts for the development of hypertension. As ENaC is
regulated by hormones such as corticosteroids and AVP [22, 23],
the potential interaction of AVP with ENaC, two important
candidate genes of their own right, becomes intriguing.
Additional studies are required to further explore the various
components of the ENaC system as candidate genes for salt-
susceptibility. The recent localization of the subunits of ENaC to
chromosomes 1 and 4 in the rat [22, 32] and the ever increasing
density of the rat genome map call for linkage studies that should
help resolve the role of the ENaC system as a major candidate
gene for salt-susceptibility.
Conclusions
As in other experimental models of hypertension, the direct
deductive candidate gene approach has not yielded so far the
culprit genes for salt-susceptibility in the Sabra model of hyper-
tension. This may not be surprising, as the candidate gene
approach is severely confounded by the deep complexity of each
candidate gene, which in fact involves an entire system complex, a
fact that is not commonly appreciated. Each candidate gene may
be affected by a number of interim steps that involve among
others its synthesis, attachment to action site, activation of
secondary pathways, and metabolism. Each one of these steps may
be the factor determining salt-susceptibility. Thus, straightforward
sequencing a portion of a candidate gene may be only a prelimi-
nary step in a very lengthy and tedious process of attempting to
prove the relevance of the candidate gene to the pathogenesis of
a clinical entity. Combined with positional cloning, however, the
candidate gene approach may be a more sensible methodological
approach to the problem, with better chances of success in
identifying the salt-susceptibility genes. As in the case of the “ob”
gene in the mouse, however, it is also possible that the genes for
salt-susceptibility may not be part of known pathophysiological
mechanisms of hypertension and that new, yet unidentified re-
sponsible proteins may be uncovered in the deductive positional
cloning approach. Once such new peptides are uncovered, they
become candidate genes, and their pathophysiological relevance
to salt-susceptibility remains to be established.
GENETIC MAPPING OF SALT-SUSCEPTIBILITY GENES
As the first strategic steps undertaken in the multi-stage process
of positional cloning of salt-susceptibility genes in the Sabra rat
model of hypertension, genetic mapping to chromosomal regions
was carried out in cross-bred SBH/y and SBN/y rats [33]. The BP
response to salt-loading was determined in the F2 generation, the
mode of transmission of salt-susceptibility was investigated, and
cosegregation studies of BP with microsatellite markers spread
throughout the rat genome and linkage analyses were performed.
Cross-breeding
Sabra hypertension-prone (SBH/y) and hypertension-resistant
(SBN/y) rats from the Barzilai Medical Center colony [13] were
cross-bred [33]. The initial cross (Cross 1a) was between 7 female
SBH/y rats and 2 male SBN/y rats. To ensure reproducibility, this
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cross was repeated (Cross 1b) between 3 female SBH/y rats and 1
male SBN/y rats. The reciprocal cross (Cross 2a) was between 3
female SBN/y and 1 male SBN/y rats and repeated (Cross 2b)
between 5 female SBN/y rats and 2 male SBN/y rats. The F1
progeny from each cross were inbred (brother-sister mating) to
produce F2 generations. The F2 populations were weaned at one
month of age. The phenotype of interest, BP response to salt-
loading, was determined by measuring basal BP at six weeks of age
and again after four weeks of treatment with DOCA-salt, as
previously described [13].
Mode of transmission of salt-susceptibility
Analyses of the pedigrees leading from the parent progenies
through F1 to the F2 generations uncovered a highly unusual and
complex mode of transmission, as detailed below:
Cross 1. In cross 1 (female SBH/y with male SBN/y), the BP
response to salt-loading of the F1 cohort (N 5 51) was unimodal,
with a widespread distribution throughout the BP scale (Fig. 2A).
Analysis after stratification by sex revealed a different BP distri-
bution between females (N 5 26) and males (N 5 25), females
having generally a lower BP response than males. In the F2 cohort
(N 5 389), a bimodal BP distribution was found with a peak at the
lower range of the scale of the BP response (no hypertensive
response) and another peak at the higher end (hypertensive
response; Fig. 3A). The bimodality was explained in part by
differences in BP distribution between males (N 5 179) and
females (N 5 210): About 2/3 of the males tended to have a BP
response in the higher range and 1/3 in the lower range, whereas
2/3 of the females had a BP response in the lower range and 1/3
in the higher range.
Fig. 2. Blood pressure (BP) distribution after salt-loading with DOCA-
salt in F1 cohort of cross 1 (A) and cross 2 (B). Symbols are: (M) female;
(f) male. Fig. 3. Blood pressure (BP) distribution after salt-loading with DOCA-
salt in F2 cohort of cross 1 (A) and cross 2 (B). Symbols are: (M) female;
(f) male.
Fig. 4. Scheme of proposed Mendelian mode of transmission of the
salt-resistance n-allele in crosses 1 and 2, accounting for the rise in blood
pressure (BP) after salt-loading in females in cross 1 and the lack of
hypertensive response in cross 2.
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Cross 2. In Cross 2 animals, the reciprocal cross (male SBH/y
with female SBN/y), the BP response to salt-loading in F1 (N 5
78) was unimodal as in Cross 1 (Fig. 2, lower panel). Stratification
by sex revealed that BP in females was in the low range response
in most animals (28 of 31), whereas in males the BP spread evenly
throughout the scale. In the F2 cohort (N 5 338), BP distribution
was bimodal (Fig. 3B), similar to that found in Cross 1. After
stratification by sex, the BP response in males (N 5 167) was
found bimodal, with about half of the animals having a lower
response and half having a hypertensive response. Females (N 5
171) had nearly all BP measurements (N 5 166) in the low range.
This complex and highly unusual mode transmission of the BP
response to salt-loading in the F1 and F2 generations in these
crosses is presently difficult to interpret. The bimodal distribution
of BP and sexual dimorphism are, nonetheless, highly suggestive
of the following three possibilities: (1) That at least two major
separate salt-susceptibility autosomal genes must be involved
among the sexes, one accounting for salt-sensitivity (the hyper-
tensive response) and the other for salt-resistance (the lack of a
hypertensive response); (2) different sets of autosomal genes may
account for salt-susceptibility in males and females; (3) a major
salt-resistance dominant allele on the X chromosome modulates
expression (inhibitory effect) of the salt-sensitive autosomal genes
in females. The salt-resistance allele on the X chromosome
appears to be transmitted in a pattern of Mendelian dominance
(Fig. 4), since in the presence of an allele for resistance on
Chromosome X in F1 of crosses 1 and 2 in all females (Xn), there
was a lack of hypertensive response. In contrast, in F2 of cross 1,
females could develop hypertension as only some but not all
carried the resistance allele, thus allowing the autosomes to come
into action, whereas in cross 2, all females carried the N allele and
thus BP did not rise in response to salt.
Fig. 5. Linkage map for rat chromosome 1 based on data from 232 rats (100 male and 132 female - overall effect). The blood pressure (BP) effect was
calculated as the difference in BP between the homozygous for the H (salt-sensitive hypertensive) allele and those homozygous for the N (salt-resistant
normotensive) allele. The arrow indicates the maximum LOD score and the QTL vertical bar indicates 6 1 LOD for linkage to BP.
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Genetic mapping
Random genome-wide screen was performed in the Sabra
model of hypertension with 210 microsatellite markers distributed
over the 20 rat autosomes and covering 96.8% of the rat genome
[33]. Genotyping was carried out as previously described [13]. The
data were analyzed to determine if BP after salt-loading cosegre-
gated with markers on chromosomes 1 to 20, and multipoint
linkage analyses were performed using the MAPMAKER/EXP
3.0 and MAPMAKER/QTL 1.1 programs [34, 35]. As the mode of
inheritance of salt-susceptibility in this cross was found highly
complex (see section above), the free default model was used for
calculations. The resulting analyses showed that BP after salt
loading cosegregated significantly with well defined regions on
chromosomes 1 and 17. There was no cosegregation with markers
on any of the other autosomes [33]. Analyses of chromosome X
data are still ongoing.
Chromosome 1. Analysis of the data from the entire F2 cohort
detected two QTLs on chromosome 1 (Fig. 5). One, designated
SS1a, with a peak LOD score of 4.71 and a span of 64.9
centimorgans (cM; Max LOD score 6 1), accounted for 43% of
the difference in the BP response to salt-loading between SBH/y
and SBN/y. The second QTL, designated SS1b, has a peak LOD
score of 4.91 and a span of 17.2 cM, and accounts for 35% of the
difference in the BP pressure response between SBH/y and
SBN/y. Repeat analysis of the data after stratification by sex
revealed sexual dimorphism (Fig. 6). In males, two QTL were
detected, one coinciding with SS1a with a peak LOD score of 4.52
and accounting for 59% of the difference in the BP response, and
the other coinciding with SS1b, with a peak LOD score of 2.98 and
accounting for 44% of the difference in BP response to salt-
loading. In females, only one QTL was detected on this chromo-
some, coinciding with SS1b, with a peak LOD score of 3.08, a span
of 18 cM, and accounting for 30% of the difference in the BP
response to salt-loading between SBH/y and SBN/y.
Chromosome 17. Analysis of the data from the entire F2 cohort
detected one QTL designated SS17, with a peak LOD score of
3.43, a span of 15.8 cM and accounting for 31% of the difference
in the BP response to salt-loading between SBH/y and SBN/y. In
males, repeat analysis after stratification by sex revealed no
cosegregation of any region on chromosome 17 with the BP
response to salt-loading, whereas in females one QTL was de-
tected, coinciding with SS17, with a peak LOD score of 3.66, a
span of 16.3 cM, and accounting for 38% of the difference in the
BP response to salt-loading between SBH/y and SBN/y.
Comments
Genetic mapping has thus far allowed the identification of two
loci on chromosome 1 and one locus on chromosome 17 as
carrying genes that allegedly contribute to the genetic variance of
the BP response to dietary salt intake [33]. The two QTLs on
chromosome 1, SS1a and SS1b, are about 20 cM apart, do not
overlap, and most likely represent two distinct gene loci. The one
QTL on chromosome 17, SS17, is likely to represent a third gene.
Thus, salt-susceptibility in the Sabra rats appears to map to three
distinct gene loci on chromosomes 1 and 17. Comparison of these
findings with respect to salt-susceptibility related gene loci in
Fig. 6. Tracing of LOD score along
chromosomes 1 (A) and 17 (B) for blood
pressure (BP) after salt-loading as generated
by MAPMAKER/QTL, based on an analysis of
the F2 cohort. The dashed horizontal lines
represent LOD 5 3. The dotted curved lines in
the lower panels represent the entire cohort
analysis upon which the LOD scores by sex are
superimposed as continuous curved lines.
Yagil and Yagil: Salt-susceptibility in the Sabra rat1498
crosses involving the Dahl rats reveals intriguing parallels. In male
hybrids from a cross of the Dahl SS with the Lewis rats (LEW/
NCrLBR), two QTLs were detected on rat chromosome 1 [4] and
one on chromosome 17 [5]. The localization of the QTLs on
chromosome 1 at cytochrome P450 2B2 [4, 36] and SA [4, 37] loci
correspond well with the placement estimates of SS1a and SS1b.
The QTL detected in the cross of the Dahl SS with the Lewis rats
on chromosome 17 [38] also corresponds well with the placement
of SS17. The sexual dimorphism in the genetic basis of salt-
susceptibility that was uncovered in the Sabra model is novel. In
the male rats, two culprit QTLs were localized to chromosome 1,
coinciding with SS1a and SS1b and in the female rats, one QTL
was detected on chromosome 1 coinciding with SS1b, and a
second QTL on chromosome 17. These findings suggest that SS1a
is sex specific for males, that SS17 is sex specific for females,
whereas SS1b is not sex specific. If the effects of the two genes
encoded within these QTLs are additive, in male Sabra rats, the
BP response to salt-loading can be entirely accounted for by the
two QTLs detected on chromosome 1, whereas in the female
Sabra rats, chromosomes 1 and 17 together contribute to nearly
70% of the BP response to salt-loading. Thus, while the combined
effects of SS1a and SS1b account for a large portion of the overall
phenotype variance in male rats, it would appear that other, yet
unidentified genetic loci must contribute additionally to the
genetic variance in females, indicating the need to pursue the
search for additional gene loci at other chromosomal locations.
The sex specificity with respect to the effects of QTLs SS1a and
SS17 implies that different sets of autosomal genes may contrib-
ute to salt-susceptibility and hypertension among either sexes.
Such sex specificity of QTLs is consistent with reports in other
strains of genetically hypertensive rats [39]. While epistatic and
ecogenetic interactions of genes with the Y and X chromosomes
may come into play, hormonal interaction at the transcriptional as
well as post-translational level represent an alternative possibility
that needs to be addressed in future studies by including appro-
priate hormonally and surgically modified experimental groups.
Finally, genetic mapping as part of the overall strategy of posi-
tional cloning leads eventually to identification of candidate
genes, whether known or novel proteins. The large number of
potential candidate genes already identified in the areas swept by
the placement confidence intervals for SS1a, SS1b, and SS17,
virtually precludes further evaluation of the present results with
respect to gene identification, until higher resolution linkage
information becomes available. Such information should be forth-
coming from congenic substrains currently under construction.
The congenic strains will also help clarify the significance of the
identified QTLs and determine if they indeed encode the putative
genes for salt-sensitivity or for resistance in terms of the develop-
ment of hypertension.
SUMMARY
The current search for salt-susceptibility genes in the Sabra
model of hypertension has involved the deductive candidate gene
approach and the inductive positional cloning scheme, consisting
of random screening of the entire rat genome for the culprit genes
and chromosomal mapping. The candidate gene approach has
focused on several interesting candidate systems, including the
nitric oxide system, arginine vasopressin, and the epithelial so-
dium channel complex. Each system-complex involves a large
number of peptides and reactions, and each of these could be
involved as an intermediary step in the genesis of salt-susceptibil-
ity. The likelihood of detecting the actual responsible genes for
salt-susceptibility using this methodology alone is thus low and the
process, however important, is slow and high risk in terms of
cost-effect. Forthcoming efforts will most likely need to combine
the candidate gene approach with positional cloning. The initial
step in positional cloning consisting of genetic mapping has led us,
as an interim step, to investigate the mode of transmission of
salt-susceptibility, which we found highly unusual and complex,
suggesting involvement of at least two sets of autosomal genes
that may be different in male and females, and the presence of an
inhibitory allele on the X chromosome in females. Using linkage
analyses, we detected two QTLs for salt-susceptibility on chromo-
some 1, and one QTL on chromosome 17. We found sex
specificity with one QTL specific for males only, one specific for
females only, and a third involving both males and females. Thus,
different susceptibility genes for hypertension might come into
play between the sexes in the Sabra model of salt-susceptibility.
Even though it may be reasonable to interpret our findings in a
more general sense, it is important to stress that our findings apply
only to the specific strains and experimental conditions studied.
Thus, extrapolations to other models, and certainly to human
traits, should be made with great caution. It is apparent, none-
theless, that further exploration of the Sabra model of salt-
susceptibility, the eventual identification of causative genes, and
the decoding of the mechanism of action in this experimental
model, may ultimately provide clinically relevant tools for novel
diagnostic and therapeutic approaches that will benefit an epide-
miologically important group of patients with hypertension.
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